"O-17 A TNM-Immune (TNM-I) classification staging system for predicting survival in colon cancer in a multicenter international SITC study" by B. Mlecnik

Selected Works of Carlo B. Bifulco, M.D.

Article

O-17 A TNM-Immune (TNM-I) classification staging system for predicting survival in colon cancer in a multicenter international SITC study

Annals of Oncology (2020)

B. Mlecnik, French Institute of Health and Medical Research
C. Bifulco, Earle A. Chiles Research Institute at Robert W. Franz Cancer Center, Providence, Portland, United States
F. Marliot, University of Paris
A. Lugli, University of Bern
I. Nagtegaal, Department of Pathology, Radboud UMC, Nijmegen, Netherlands
A. Hartmann, University of Erlangen-Nuremberg
M. Van den Eynde, Université catholique de Louvain
M. Roehrl, Memorial Sloan Kettering Cancer Center
P. Ohashi, Princess Margaret Cancer Centre
E. Zavadova, First Faculty of Medicine, Charles University in Prague
T. Torigoe, Sapporo Medical University
P. Patel, The Gujarat Cancer and Research Institute, Ahmedabad, India
Y. Wang, Xi'an Jiaotong University
Y. Kawakami, Keio University
F. Hermitte, HalioDx, Marseille, France
F. Marincola, AbbVie
P. Ascierto, National Tumour Institute Fondazione G. Pascale, Naples, Italy
B. Fox, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, Portland, United States
F. Pagès, University of Paris
J. Galon, French Institute of Health and Medical Research

Link

Disciplines

Publication Date

July 1, 2020

DOI

10.1016/J.ANNONC.2020.04.070

Citation Information

B. Mlecnik, C. Bifulco, F. Marliot, A. Lugli, et al.. "O-17 A TNM-Immune (TNM-I) classification staging system for predicting survival in colon cancer in a multicenter international SITC study" Annals of Oncology Vol. 31 (2020) p. 238
Available at: http://works.bepress.com/carlo-bifulco/51/